EIGER BIOPHARMACEUTICALS INC (EIGR) Stock Analyst Ratings

NASDAQ:EIGR • US28249U2042

1.725 USD
-0.17 (-9.21%)
At close: Apr 10, 2024
1.7 USD
-0.03 (-1.45%)
After Hours: 4/10/2024, 8:00:01 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

88

ChartMill assigns a Buy % Consensus number of 88% to EIGR. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 91.8. This target is 5221.74% above the current price.
  • EIGR was analyzed by 8 analysts. The buy percentage consensus is at 88. So analysts seem to be very confident about EIGR.
  • In the previous month the buy percentage consensus was at a similar level.
  • EIGR was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
EIGR Historical Analyst RatingsEIGR Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.7330.3091.8091.80157.50 - 1,656.52% 5,221.74% 5,221.74% 9,030.43%

Related screens

Find peers 30% below price target
EIGR Current Analyst RatingEIGR Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-08-29 Citigroup Maintains Buy -> Buy
2023-06-30 Baird Maintains Outperform -> Outperform
2022-09-07 BTIG Maintains Buy
2021-08-09 Citigroup Maintains Buy

EIGER BIOPHARMACEUTICALS INC / EIGR FAQ

What do analysts expect the price target to be for EIGER BIOPHARMACEUTICALS INC (EIGR)?

8 analysts have analysed EIGR and the average price target is 91.8 USD. This implies a price increase of 5221.74% is expected in the next year compared to the current price of 1.725.


How do analysts rate EIGER BIOPHARMACEUTICALS INC (EIGR)?

The consensus rating for EIGER BIOPHARMACEUTICALS INC (EIGR) is 87.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for EIGR stock?

The number of analysts covering EIGER BIOPHARMACEUTICALS INC (EIGR) is 8.